Health

  • Eating dairy products may cut bowel cancer risk: Study
    Toronto, September 29 (IANS): Eating dairy products may reduce bowel cancer risk, but there's no evidence that garlic or onions, fish, tea or coffee protect against the disease, say researchers. For the findings, published in the journal Gut, the research team McGill University in Canada, trawled relevant published systematic reviews and meta-analyses of clinical trials and observational studies assessing the impact of dietary and medicinal factors on bowel cancer risk. The m
  • Serum Institute to manufacture 200mn doses of Covid-19 vaccine
    New Delhi, September 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi and the Bill and Melinda Gates Foundation will accelerate the manufacture and delivery of up to 100 million doses of safe and effective Covid-19 vaccines for India and low-and middle income countries. This brings the total number of vaccine doses to be covered by the partnership between SII, Gavi, and the Gates Foundation
  • Are men at a greater risk of heart disease than women?
    New Delhi, September 29 (IANSlife): Over the years, multiple researches have concluded that heart disease impacts men and women differently. It has been noted that in the younger age groups, men are at a far higher risk of heart disease than women; on an average, while the disease strikes men at 65 years of age, women may experience it when they are closer to 72 years. In recent years, scientists and clinicians have poured over immense amount of data to understand this phenomenon be
  • Clinical trial of Ayurvedic remedy for Covid-19 shows groundbreaking results
    New Delhi, September 28 (IANS): A groundbreaking interim report on a clinical trial being conducted in three hospitals has shown that Covid-19 patients on natural treatment are resolving most symptoms earlier than those on conventional medicines. The interim report on combination treatment of an Ayurvedic remedy called 'Immunofree' by Corival Life Sciences, and Nutraceutical called 'Reginmune' by Biogetica have shown exceptional results as against the present governm
  • Healthy at Heart
    New Delhi, September 28 (IANSlife): This World Heart Day, let's have a light-hearted conversation about the importance of having a healthy heart and how one should take care of it. Being aware of cardiovascular diseases and measures to prevent them is of utmost importance to all of us, especially adults of over 40 years of age, to ensure they follow a healthy routine. Leading an unhealthy lifestyle, stress, excessive intake of salt and sugar through can result in high blood pres
  • Treating the heart with scientific breakthroughs, lifestyle changes
    New Delhi, September 27 (IANSlife): From the time the first Coronavirus case was recorded in China, to India's numbers crossing four million, COVID-19 has millions of lives under its ambit. Now, for a country like India, where the cardiovascular disease burden is already at an alarming high, these are threatening facts. Moreover, pandemic-induced lockdowns have also raised stress levels which can induce heart related ailments. On this World Heart Day, here are some thoughts by D
  • 'Vitamin D cuts complications, risk of death in Covid patients'
    New York, September 26 (IANS): A new research adds to the growing body of evidence that patients with sufficient levels of Vitamin D are less likely to experience complications and die from Covid-19. According to the study, published in the journal PLOS ONE, hospitalised Covid-19 patients who were vitamin D sufficient, with a blood level of 25-hydroxyvitamin D of at least 30 ng/mL (a measure of vitamin D status) had a significantly decreased risk for adverse clinical outcomes and de
  • 9 ways to build resilience and tackle mental health problems
    New Delhi, September 26 (IANSlife): Covid-19 has triggered a global financial crisis and due to strict adoption of lockdown measures, the magnitude of poor mental health is increasing across the world. The 'New Normal' hopes to bring a positive outcome, but the fear of contracting the virus is making it difficult for people to live through these times. All we need is to do is go back to basics and work on maintaining mental health by sculpting resilience on a daily basis. Re
  • People aged between 30-40 coming with new-found cardio issues
    New Delhi, September 26 (IANS): Respiratory disorders caused by Covid-19 have taken a centre-stage during the pandemic, overshadowing other burgeoning health issues, particularly cardiovascular disorders (CVDs). With the recent uptick in heart diseases over the last few months, people are facing the likelihood of cardiovascular concerns at a large scale. The incidences of new-onset and worsening heart problems are being highlighted by medical experts. However, a worrying trend is be
  • Does the cure for Coronavirus symptoms lie in natural medicine?
    New Delhi, September 26 (IANSlife): In the last eight months of the Coronavirus pandemic, enough cases have been made for supplementing Covid-19 treatment with natural medicine. Data emerging from multiple locations has recorded a decline in mortality rates in the states and countries who have incorporated natural medicine for immune boosting and to aid recovery from Covid-19. China was among the first to set this trend as the Chinese Government mandated the use of traditional Chine
  • Before vaccine comes, global death toll may hit 2 mn: WHO
    Geneva, September 26 (IANS): The World Health Organization (WHO) warned that the global coronavirus death toll could hit two million before an effective vaccine is widely used. WHO emergencies head Mike Ryan on Friday said the figure could be even higher without concerted international action, the BBC reported. The number of Covid-19 deaths is fast approaching one million - nine months after the outbreak started in China. Ryan also urged Europeans to ask themselves whether the
  • Common diabetes drug linked to low risk of major heart issues
    Toronto, September 24 (IANS): Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers. According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo. But some of the
  • Men at 62% increased risk of Covid associated deaths: Study
    London, September 24 (IANS): New research has added to the growing body of evidence that men have a 62 per cent greater risk of Covid-19 associated death compared to women, possibly due to higher levels of inflammation. Increasing evidence suggests a gender difference in SARS-CoV-2 infections. In most cohorts, men are overrepresented and previously published data show a higher incidence of severe courses of Covid-19 in men. According to the study presented on at ESCMID Conference
  • Breathing problems key reason for not wearing masks: Study
    New Delhi, September 24 (IANSlife): When it came to non-compliance towards covering face, breathing problems have emerged as a key reason, with 50 percent listing it in a nationwide survey, followed by discomfort and inconvenience at 44 per cent. Around 45 percent also assume that as long as social distancing was maintained, a mask was not required. The survey, spread over 18 cities, was initiated by ApnaMask, an initiative by EkDesh, to understand overall compliance around wearing
  • Fujifilm's Avigan shown to be effective in Japanese Phase-3 trial for COVID-19
    TOKYO, September 23 (Reuters) : Fujifilm Holdings Corp said on Wednesday a late-stage study of its antiviral drug Avigan showed it reduced recovery times for COVID-19 patients with non-severe symptoms, boosting expectations for regulatory approval in Japan. The Phase 3 clinical study of 156 patients in Japan showed that those treated with Avigan improved after 11.9 days, versus 14.7 days for a placebo group. Results of the study, conducted by subsidiary Fujifilm Toyama Chemical, wer
  • Punjab to start Covaxin's Phase-3 trials
    Chandigarh, September 22 (IANS): Punjab's three Government Medical Colleges will participate in the Phase-3 trials of Bharat Biotech Ltd's Covaxin, the first indigenously-developed vaccine candidate against coronavirus, in collaboration with the Indian Council of Medical Research (ICMR), an official said on Tuesday. The trials are scheduled to commence from October 15. This was disclosed by a government spokesperson fter a virtual Covid review meeting chaired by Chief Min
  • Study suggests dengue may provide some immunity against COVID-19
    RIO DE JANEIRO, September 22 (Reuters) - A new study that analyzed the coronavirus outbreak in Brazil has found a link between the spread of the virus and past outbreaks of dengue fever that suggests exposure to the mosquito-transmitted illness may provide some level of immunity against COVID-19. The not yet published study led by Miguel Nicolelis, a professor at Duke University, and shared exclusively with Reuters, compared the geographic distribution of coronavirus cases with the
  • Breast cancer drug shows promise to change prostate cancer treatment
    London, September 21 (IANS): A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer, showed results of a major trial which could change clinical practice. Final results from the trial showed that olaparib -- a pioneering type of drug called a PARP inhibitor, a cancer drug to target an inherited genetic fault -- can be used successfully to treat prostate cancers with a weakness in their ability to repair damaged DNA. The drug was more
  • Over 60K sign up for Russian Covid vax, 700 injected
    Moscow, September 21 (IANS): More than 60,000 people have applied to volunteer for the coronavirus vaccine trials in Moscow and over 700 people have been injected with the coronavirus vaccine, the media reported. Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered on August 11. "Over 60,000 people have signed up as volunteers,
  • Certain cancer treatments up death risk from Covid-19: Study
    New York, September 20 (IANS): A team of US researchers has found that certain treatments for cancer may increase the chance of death if they contract Covid-19. The study by the researchers at the University of Cincinnati, presented at the European Society for Medical Oncology Virtual Congress 2020, shed light on ways standard anti-cancer treatments may impact outcomes for patients with both cancer and the coronavirus. "Patients with cancer are susceptible to infection from